Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5‐aminolevulinic acid induced protoporphyrin IX

Tobias Beck(Ludwig-Maximilians-Universität München), Reinhold Baumgartner(Ludwig-Maximilians-Universität München), Herbert Stepp, Wolfgang Beyer(Ludwig-Maximilians-Universität München), Walter Stummer(University of Münster), Friedrich W. Kreth(Ludwig-Maximilians-Universität München), Jan H. Mehrkens(Ludwig-Maximilians-Universität München), Andreas Obermeier
Lasers in Surgery and Medicine
June 1, 2007
10.1002/lsm.20507
Cited by 200

Related Papers

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k
Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients
|Journal of neurosurgery|2000|880
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
|The Lancet|2019|581
What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
|Neurosurgery|2015|368